TradingView
RocketTickers
Jun 24, 2020 6:13 PM
Rhythm Pharmaceuticals Announces Positive Results from Phase 2 S
Long
NASDAQ:RYTM
15
Rhythm Pharmaceuticals, Inc.
NASDAQ
Description
⋅
Jun 24, 2020 6:13 PM
RYTM: Rhythm Pharmaceuticals, Inc.
2020-06-24 08:00:10
Rhythm Pharmaceuticals Announces Positive Results from Phase 2 Study of Once-weekly Formulation of Setmelanotide in Healthy Obese Volunteers
Beyond Technical Analysis
More